Procedural Safety and Predictors of Acute Outcome of Intracoronary Administration of Progenitor Cells in 775 Consecutive Procedures Performed for Acute Myocardial Infarction or Chronic Heart Failure [Myocardial Infarction]

Conclusions— Intracoronary infusion of progenitor cells can be performed with adequate safety in patients with acute myocardial infarction or CHF, because the safety profile was similar to what is usually expected from a coronary angiogram in the present cohort. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00962364, NCT00284713, and NCT00289822.
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Tags: Other myocardial biology, Catheter-based coronary and valvular interventions: other Myocardial Infarction Source Type: research